Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-17

Clinical Trial Update: Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis. [NA]

View source ↗

Summary

A clinical trial is planned to evaluate trilinolein cream for preventing relapse in patients with moderate-to-severe atopic dermatitis who are in remission; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trilinolein Cream (trilinolein)

Snippet

Sponsor: Shanghai Yueyang Integrated Medicine Hospital | Conditions: Atopic Dermatitis | NA | Status: NOT_YET_RECRUITING